4 completed, 1 active not recruiting, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow AIDS-Associated Nephropathy: new trials by email Literature Review of AIDS-Associated Nephropathy trials Research Report on AIDS-Associated Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1 Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Unknown | Assistance Publique - Hôpitaux de Paris | 124 | 2024-06-30 | 2024-06-05 | |
| Genetic Determinants of Kidney Disease in People of African Ancestry With HIV HIV Nephropathy, Kidney Injury | Active not recruiting | King's College Hospital NHS Trust | 3029 | 2018-05-01 | 2025-09-03 | |
| Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients Chronic Kidney Failure, AIDS-Associated Nephropathy | Completed | Children's National Research Institute | 320 | 2004-09-01 | 2008-05-05 | |
| Genetic Markers for Focal Segmental Glomerulosclerosis Focal Segmental Glomerulosclerosis, HIV-Associated Focal Segmental Glomerulosclerosis | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 616 | 1996-04-15 | 2026-10-26 | |
| A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease Nelfinavir mesylate, Saquinavir, Lamivudine - HIV Infections, AIDS-Associated Nephropathy | Phase 3 | Completed | Hoffmann-La Roche | 24 | 2005-06-24 | |
| A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN) Prednisone - HIV Infections, AIDS-Associated Nephropathy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 54 | 2021-10-29 |
HIV Infections (3) · Glomerulosclerosis, Focal Segmental (2) · Kidney Diseases (2) · Kidney Failure, Chronic (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Genetic Predisposition to Disease (1) · Nephrosis, Lipoid (1) · Nephrotic Syndrome (1) · Obesity (1)
Blood-Borne Infections (6) · Communicable Diseases (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Immune System Diseases (6) · Immunologic Deficiency Syndromes (6) · Infections (6) · Lentivirus Infections (6) · Male Urogenital Diseases (6) · RNA Virus Infections (6) · Retroviridae Infections (6) · Sexually Transmitted Diseases (6) · Sexually Transmitted Diseases, Viral (6) · Urogenital Diseases (6)
Lamivudine (1) · Nelfinavir (1) · Prednisone (1) · Saquinavir (1) · Stavudine (1)
Assistance Publique - Hôpitaux de Paris (1) · Children's National Research Institute (1) · Hoffmann-La Roche (1) · King's College Hospital NHS Trust (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (4) · France (1) · United Kingdom (1)
Anirban Ganguli, M.D. (1) · Frank A Post (1) · Kalayjian R (1) · Kevin D. McBryde, MD (1) · Lederman M (1) · Smith MC (1) · Susan L. Furth, MD, PhD (1)
PMID 33927087, PMID 34286237, PMID 34546112, PMID 35257059, PMID 35497797, PMID 35967115, PMID 36728909, PMID 36921326, PMID 38213094, PMID 38265411, PMID 38377277, PMID 38529684, PMID 38666627, PMID 39209512, PMID 39448372, PMID 39593273, PMID 39791983, PMID 40063203, PMID 40227084